AFP and cancer: Fraction AFP-L3% (i.e., AFP fraction binding to Lens culinaris agglutinin—LCA) may be used to distinguish between benign and malignant tumours (i.e., a predictive biomarker) [109], but the same form of AFP has been produced by HCC [110].